-
1
-
-
0347444723
-
MicroRNAs: Genomics, biogenesis, mechanism, and function
-
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
2
-
-
81355142141
-
Non-coding RNAs in human disease
-
Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
-
(2011)
Nat Rev Genet
, vol.12
, pp. 861-874
-
-
Esteller, M.1
-
4
-
-
20144373433
-
Reduced expression of Dicer associated with poor prognosis in lung cancer patients
-
Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96: 111-115.
-
(2005)
Cancer Sci
, vol.96
, pp. 111-115
-
-
Karube, Y.1
Tanaka, H.2
Osada, H.3
Tomida, S.4
Tatematsu, Y.5
Yanagisawa, K.6
-
5
-
-
58049213696
-
Dicer, Drosha, and outcomes in patients with ovarian cancer
-
Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359: 2641-2650.
-
(2008)
N Engl J Med
, vol.359
, pp. 2641-2650
-
-
Merritt, W.M.1
Lin, Y.G.2
Han, L.Y.3
Kamat, A.A.4
Spannuth, W.A.5
Schmandt, R.6
-
6
-
-
84923276259
-
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
-
Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM et al. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun 2014; 5: 5202.
-
(2014)
Nat Commun
, vol.5
, pp. 5202
-
-
Rupaimoole, R.1
Wu, S.Y.2
Pradeep, S.3
Ivan, C.4
Pecot, C.V.5
Gharpure, K.M.6
-
7
-
-
84923289688
-
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
-
van den Beucken T, Koch E, Chu K, Rupaimoole R, Prickaerts P, Adriaens M et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat Commun 2014; 5: 5203.
-
(2014)
Nat Commun
, vol.5
, pp. 5203
-
-
Van Den Beucken, T.1
Koch, E.2
Chu, K.3
Rupaimoole, R.4
Prickaerts, P.5
Adriaens, M.6
-
8
-
-
0036359548
-
Hypoxia-A key regulatory factor in tumour growth
-
Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 38-47
-
-
Harris, A.L.1
-
9
-
-
0042411985
-
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
-
Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev 2003; 29: 297-307.
-
(2003)
Cancer Treat Rev
, vol.29
, pp. 297-307
-
-
Shannon, A.M.1
Bouchier-Hayes, D.J.2
Condron, C.M.3
Toomey, D.4
-
10
-
-
34547121206
-
Hypoxia in cancer: Significance and impact on clinical outcome
-
Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225-239.
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 225-239
-
-
Vaupel, P.1
Mayer, A.2
-
11
-
-
33749441325
-
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
-
Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006; 116: 2610-2621.
-
(2006)
J Clin Invest
, vol.116
, pp. 2610-2621
-
-
Mancuso, M.R.1
Davis, R.2
Norberg, S.M.3
O'Brien, S.4
Sennino, B.5
Nakahara, T.6
-
12
-
-
84877039223
-
Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells
-
Yamagishi N, Teshima-Kondo S, Masuda K, Nishida K, Kuwano Y, Dang DT et al. Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells. BMC Cancer 2013; 13: 229.
-
(2013)
BMC Cancer
, vol.13
, pp. 229
-
-
Yamagishi, N.1
Teshima-Kondo, S.2
Masuda, K.3
Nishida, K.4
Kuwano, Y.5
Dang, D.T.6
-
13
-
-
70349168446
-
Hypoxiainducible mir-210 regulates normoxic gene expression involved in tumor initiation
-
Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK et al. Hypoxiainducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009; 35: 856-867.
-
(2009)
Mol Cell
, vol.35
, pp. 856-867
-
-
Huang, X.1
Ding, L.2
Bennewith, K.L.3
Tong, R.T.4
Welford, S.M.5
Ang, K.K.6
-
14
-
-
33847234988
-
A microRNA signature of hypoxia
-
Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ et al. A microRNA signature of hypoxia. Mol Cell Biol 2007; 27: 1859-1867.
-
(2007)
Mol Cell Biol
, vol.27
, pp. 1859-1867
-
-
Kulshreshtha, R.1
Ferracin, M.2
Wojcik, S.E.3
Garzon, R.4
Alder, H.5
Agosto-Perez, F.J.6
-
15
-
-
79951678403
-
MiR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
-
Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 2011; 18: 465-478.
-
(2011)
Cell Death Differ
, vol.18
, pp. 465-478
-
-
Puissegur, M.P.1
Mazure, N.M.2
Bertero, T.3
Pradelli, L.4
Grosso, S.5
Robbe-Sermesant, K.6
-
16
-
-
80053259947
-
Ardehali H. MicroRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects
-
Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 2011; 301: H1519-H1530.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
, pp. H1519-H1530
-
-
Mutharasan, R.K.1
Nagpal, V.2
Ichikawa, Y.3
-
17
-
-
77950203807
-
MiR-181a and miR-630 regulate cisplatin-induced cancer cell death
-
Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 2010; 70: 1793-1803.
-
(2010)
Cancer Res
, vol.70
, pp. 1793-1803
-
-
Galluzzi, L.1
Morselli, E.2
Vitale, I.3
Kepp, O.4
Senovilla, L.5
Criollo, A.6
-
18
-
-
84874644402
-
Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility
-
Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ, Chen MW et al. Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest 2013; 123: 1082-1095.
-
(2013)
J Clin Invest
, vol.123
, pp. 1082-1095
-
-
Kuo, T.C.1
Tan, C.T.2
Chang, Y.W.3
Hong, C.C.4
Lee, W.J.5
Chen, M.W.6
-
19
-
-
78650420261
-
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
-
Dedes KJ, Natrajan R, Lambros MB, Geyer FC, Lopez-Garcia MA, Savage K et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur J Cancer 2011; 47: 138-150.
-
(2011)
Eur J Cancer
, vol.47
, pp. 138-150
-
-
Dedes, K.J.1
Natrajan, R.2
Lambros, M.B.3
Geyer, F.C.4
Ma, L.5
Savage, K.6
-
20
-
-
84878108145
-
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
-
Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 2013; 497: 383-387.
-
(2013)
Nature
, vol.497
, pp. 383-387
-
-
Shen, J.1
Xia, W.2
Khotskaya, Y.B.3
Huo, L.4
Nakanishi, K.5
Lim, S.O.6
-
21
-
-
77958558613
-
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
-
Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986-990.
-
(2010)
Nature
, vol.467
, pp. 986-990
-
-
Su, X.1
Chakravarti, D.2
Cho, M.S.3
Liu, L.4
Gi, Y.J.5
Lin, Y.L.6
-
22
-
-
84886048409
-
Wu M. C-Myc modulates microRNA processing via the transcriptional regulation of Drosha
-
Wang X, Zhao X, Gao P, Wu M. c-Myc modulates microRNA processing via the transcriptional regulation of Drosha. Sci Rep 2013; 3: 1942.
-
(2013)
Sci Rep
, vol.3
, pp. 1942
-
-
Wang, X.1
Zhao, X.2
Gao, P.3
-
23
-
-
84891882468
-
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
-
Allegra D, Bilan V, Garding A, Dohner H, Stilgenbauer S, Kuchenbauer F et al. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. Leukemia 2014; 28: 98-107.
-
(2014)
Leukemia
, vol.28
, pp. 98-107
-
-
Allegra, D.1
Bilan, V.2
Garding, A.3
Dohner, H.4
Stilgenbauer, S.5
Kuchenbauer, F.6
-
24
-
-
77953898940
-
A microRNA targeting dicer for metastasis control
-
Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S et al. A microRNA targeting dicer for metastasis control. Cell 2010; 141: 1195-1207.
-
(2010)
Cell
, vol.141
, pp. 1195-1207
-
-
Martello, G.1
Rosato, A.2
Ferrari, F.3
Manfrin, A.4
Cordenonsi, M.5
Dupont, S.6
-
25
-
-
55549127406
-
Takahashi T. Let-7 regulates Dicer expression and constitutes a negative feedback loop
-
Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008; 29: 2073-2077.
-
(2008)
Carcinogenesis
, vol.29
, pp. 2073-2077
-
-
Tokumaru, S.1
Suzuki, M.2
Yamada, H.3
Nagino, M.4
-
26
-
-
84887467125
-
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
-
Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Disc 2013; 3: 1302-1315.
-
(2013)
Cancer Disc
, vol.3
, pp. 1302-1315
-
-
Nishimura, M.1
Jung, E.J.2
Shah, M.Y.3
Lu, C.4
Spizzo, R.5
Shimizu, M.6
-
27
-
-
78650624101
-
RNA interference in the clinic: Challenges and future directions
-
Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 2011; 11: 59-67.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 59-67
-
-
Pecot, C.V.1
Calin, G.A.2
Coleman, R.L.3
Lopez-Berestein, G.4
Sood, A.K.5
-
28
-
-
84887251722
-
Tumour angiogenesis regulation by the miR-200 family
-
Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C et al. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 2013; 4: 2427.
-
(2013)
Nat Commun
, vol.4
, pp. 2427
-
-
Pecot, C.V.1
Rupaimoole, R.2
Yang, D.3
Akbani, R.4
Ivan, C.5
Lu, C.6
-
29
-
-
84877058177
-
Src activation by beta-adrenoreceptors is a key switch for tumour metastasis
-
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG et al. Src activation by beta-adrenoreceptors is a key switch for tumour metastasis. Nat Commun 2013; 4: 1403.
-
(2013)
Nat Commun
, vol.4
, pp. 1403
-
-
Armaiz-Pena, G.N.1
Allen, J.K.2
Cruz, A.3
Stone, R.L.4
Nick, A.M.5
Lin, Y.G.6
-
30
-
-
84896259886
-
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity
-
Wu SY, Yang X, Gharpure KM, Hatakeyama H, Egli M, McGuire MH et al. 2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity. Nat Commun 2014; 5: 3459.
-
(2014)
Nat Commun
, vol.5
, pp. 3459
-
-
Wu, S.Y.1
Yang, X.2
Gharpure, K.M.3
Hatakeyama, H.4
Egli, M.5
McGuire, M.H.6
-
31
-
-
23044506285
-
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
-
Landen Jr CN, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 2005; 65: 6910-6918.
-
(2005)
Cancer Res
, vol.65
, pp. 6910-6918
-
-
Landen, C.N.1
Chavez-Reyes, A.2
Bucana, C.3
Schmandt, R.4
Deavers, M.T.5
Lopez-Berestein, G.6
|